Navigation Links
Wyeth to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
Date:1/5/2009

MADISON, N.J., Jan. 5 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) announced today that it will present at the Goldman Sachs Healthcare CEOs Unscripted Conference on Wednesday, January 7, 2009 at 8:05 a.m. Eastern Time. Presenting for Wyeth will be Bernard Poussot, Chairman, President and Chief Executive Officer.

Wyeth's presentation will be webcast live for investors at www.wyeth.com and available for replay following the conference.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare, and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements based on current expectations of future events that involve risks and uncertainties including, without limitation, risks associated with the inherent uncertainty of the timing and success of pharmaceutical research, product development, manufacturing, commercialization, economic conditions including interest and currency exchange rate fluctuations, changes in generally accepted accounting principles, the impact of competitive or generic products, trade buying patterns, wars or terrorist acts, product liability and other types of lawsuits, the impact of legislation and regulatory compliance and obtaining reimbursement, favorable drug pricing, access and other approvals, environmental liabilities, and patent, and other risks and uncertainties, including those detailed from time to time in the Company's periodi
'/>"/>

SOURCE Wyeth
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
2. Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend
3. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
4. Wyeth Announces Election of New Principal Corporate Officer
5. Wyeth Declares Preferred Stock Dividend
6. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
7. Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
8. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
9. Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent
10. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
11. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... December 25, 2014 The report “Service ... Product Type & Provider Type - Global Advancements, Worldwide ... with an in-depth analysis and forecasting of revenues. ... through 221 pages and in-depth TOC on “Service Quality ...
(Date:12/24/2014)... and NEW YORK , Dec. 24, ... company advancing patient care in critical areas, announced the closing ... stock, and warrants to purchase up to an aggregate 3,500,000 ... per share and $.01 per warrant.  The warrants have a ...
(Date:12/24/2014)... Dec. 24, 2014   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and cryopreservation ... for cells and tissues  ("BioLife" or the "Company"), today announced ... on May 4, 2015 (the "Annual Meeting"). Because ...
(Date:12/24/2014)... 23, 2014 GMO corn cases filed across ... in the process of being consolidated in a Kansas federal ... Syngenta AG MIR 162 Corn Litigation, MDL No. 2591 in ... Management of the Syngenta GMO corn multidistrict litigation (MDL) has ...
Breaking Biology Technology:Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
... Pharmaceuticals Inc. (Nasdaq: VNDA ), a biopharmaceutical ... product candidates for central nervous system disorders, today announced ... December 31, 2008. Vanda reported a net loss ... compared to $10.9 million for the third quarter of ...
... Development Conference features presentations from industry and academic speakers who ... and chemical industries. Topics include Chemical and Process R&D, ... by Design (QbD). , ... Columbia, ...
... New Mexico, February 10, 2009A team of Los Alamos ... multiplicationwhen a photon creates multiple electronsis a real phenomenon ... born of extraneous effects that mimic carrier multiplication. The ... of Chemical Research , shows the possibility of solar ...
Cached Biology Technology:Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 2Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 3Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 4Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 5Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 6Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 7Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 8Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 9Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 1016th International Process Development Conference to be Held June 14-17, 2009 in Arosa, Switzerland 2Research highlights potential for improved solar cells 2Research highlights potential for improved solar cells 3
(Date:1/22/2015)... 22, 2015 , Europe,s ... The European Patent Office to present a video retrospective of ... to be featured: Christofer Toumazou and Sophie Wilson ... and winners of the Award   Starting on 22 ...
(Date:12/22/2014)... SHELTON, Conn. , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile commerce ... consultant, Apollo Robbins for the 2015 International CES ... Apollo Robbins will be at the NXT-ID booth ...
(Date:12/19/2014)... 2014  23andMe, Inc., the leading personal genetics company, today announced ... genetic ancestry of individuals from across the United ... than four hundred years ago, the United States ... from different continents. This study illuminates how American history and ...
Breaking Biology News(10 mins):Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 423andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
... a child is born with a heart defect such as a ... to an inability to quickly and safely secure devices inside the ... stress on fragile heart tissue, and currently available clinical adhesives are ... the presence of blood or under dynamic conditions, such as in ...
... (Maximizing Access to Research Careers) Program has announced ... Society (APS) Professional Skills Training Course in Orlando, ... meant to promote the entry of underrepresented minority ... the basic science community and to encourage the ...
... in German . ... Institute of Immunobiology and Epigenetics, has sequenced and analyzed the genome ... human and other vertebrate genomes has revealed why the skeleton of ... the human skeleton and that the immune system of the shark ...
Cached Biology News:Bio-inspired glue keeps hearts securely sealed 2Bio-inspired glue keeps hearts securely sealed 3First shark genome decoded 2
sodium channel, nonvoltage-gated 1 alpha,...
MOUSE ANTI HUMAN B-CELLS (FMC7):FITC Immunogen: HRIK cells - Human B-Lymphoblastoid line...
RABBIT ANTI PARATHION...
Similar to proteasome (prosome, macropain) 26S subunit, ATPase, 1 Antigen: Recombinant Protein...
Biology Products: